Several clinical trials have suggested that estrogen ablation or anti-estrogen strategy is effective in the prevention or treatment of breast cancer, especially in estrogen receptors (ERs)-dependent breast cancer [1-3]. This evidence concerns the gene ESR1 and breast cancer.